M Koshiyama

Summary

Country: Japan

Publications

  1. ncbi Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrial carcinomas: a comparison with cisplatin
    M Koshiyama
    Department of Obstetrics and Gynecology, Tenri Hospital, Nara, Japan
    Anticancer Res 20:1353-8. 2000
  2. ncbi Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas
    M Koshiyama
    Department of Obstetrics and Gynecology, Teri Hospital, Nara, Japan
    Anticancer Res 21:2925-32. 2001
  3. ncbi The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri
    Masafumi Koshiyama
    Department of Obstetrics and Gynecology, Himeji National Hospital, 68, Honmachi, Himeji City, Hyogo 670 8520, Japan
    Cancer Detect Prev 28:94-8. 2004
  4. ncbi Intermittent, repetitive administrations of irinotecan (CPT-11) reduces its side-effects
    Haruko Fujii
    Department of Obstetrics and Gynecology, Tenri Hospital, Nara, Japan
    Cancer Detect Prev 26:210-2. 2002
  5. ncbi Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas
    M Koshiyama
    Department of Obstetrics and Gynaecology, Tenri Hospital, Tenri, Nara, Japan
    Anticancer Res 21:905-10. 2001
  6. ncbi Gynecologic malignancies accompanied by benign hormone-dependent diseases
    M Koshiyama
    Department of Obstetrics and Gynecology, Tenri Hospital, Nara, Japan
    Menopause 8:149-50. 2001
  7. ncbi Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status
    M Koshiyama
    Department of Obstetrics and Gynecology, Tenri Hospital, Nara, Japan
    Int J Cancer 74:237-44. 1997
  8. ncbi Treatment of huge uterine tumors thought to be benign in post-menopausal women
    Takako Okamoto
    Department of Obstetrics and Gynecology, Himeji National Hospital, 68 Honmachi, Himeji City, Hyogo 670-8520, Japan
    Med Sci Monit 10:CR43-5. 2004
  9. ncbi Two kinds of endometrial neoplasia arising from different origins in the uterine corpus: comparison of p53 expression and sex steroid receptor status
    Masafumi Koshiyama
    Department of Obstetrics and Gynecology, Himeji National Hospital, 68 Honmachi, Himeji, Hyogo 670 8520, Japan
    Eur J Obstet Gynecol Reprod Biol 104:167-70. 2002
  10. ncbi Adenocarcinomas arising from uterine adenomyosis: a report of four cases
    Masafumi Koshiyama
    Department of Obstetrics and Gynecology, Osaka National Hospital, Chuoku, Japan
    Int J Gynecol Pathol 21:239-45. 2002

Collaborators

Detail Information

Publications13

  1. ncbi Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrial carcinomas: a comparison with cisplatin
    M Koshiyama
    Department of Obstetrics and Gynecology, Tenri Hospital, Nara, Japan
    Anticancer Res 20:1353-8. 2000
    ..The tetrazolium dye (MTT) assay is useful in predicting chemosensitivity...
  2. ncbi Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas
    M Koshiyama
    Department of Obstetrics and Gynecology, Teri Hospital, Nara, Japan
    Anticancer Res 21:2925-32. 2001
    ..The purpose of this study was to investigate the chemosensitive and chemoresistant indices of gynecologic malignancies...
  3. ncbi The relationship between endometrial carcinoma and coexistent adenomyosis uteri, endometriosis externa and myoma uteri
    Masafumi Koshiyama
    Department of Obstetrics and Gynecology, Himeji National Hospital, 68, Honmachi, Himeji City, Hyogo 670 8520, Japan
    Cancer Detect Prev 28:94-8. 2004
    ..In brief, there are some clinicopathologic differences between the endometrial carcinoma cases with benign hormone-dependent disease and the cases without these disease...
  4. ncbi Intermittent, repetitive administrations of irinotecan (CPT-11) reduces its side-effects
    Haruko Fujii
    Department of Obstetrics and Gynecology, Tenri Hospital, Nara, Japan
    Cancer Detect Prev 26:210-2. 2002
    ..CPT-11 is useful in patients with refractory ovarian carcinomas as a second- or third-line chemotherapy...
  5. ncbi Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas
    M Koshiyama
    Department of Obstetrics and Gynaecology, Tenri Hospital, Tenri, Nara, Japan
    Anticancer Res 21:905-10. 2001
    ..The use of this index may enable prediction of a clinical response to chemotherapy using Topo II-targeting drugs in gynaecological malignancies...
  6. ncbi Gynecologic malignancies accompanied by benign hormone-dependent diseases
    M Koshiyama
    Department of Obstetrics and Gynecology, Tenri Hospital, Nara, Japan
    Menopause 8:149-50. 2001
    ..CONCLUSION: There was a higher prevalence of myoma uteri and adenomyosis uteri in postmenopausal patients with endometrial carcinomas than in the control population...
  7. ncbi Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status
    M Koshiyama
    Department of Obstetrics and Gynecology, Tenri Hospital, Nara, Japan
    Int J Cancer 74:237-44. 1997
    ..05). Our data suggest that pS2 expression is likely correlated with estrogen-related endometrial carcinoma and is possibly involved in early disease progression...
  8. ncbi Treatment of huge uterine tumors thought to be benign in post-menopausal women
    Takako Okamoto
    Department of Obstetrics and Gynecology, Himeji National Hospital, 68 Honmachi, Himeji City, Hyogo 670-8520, Japan
    Med Sci Monit 10:CR43-5. 2004
    ....
  9. ncbi Two kinds of endometrial neoplasia arising from different origins in the uterine corpus: comparison of p53 expression and sex steroid receptor status
    Masafumi Koshiyama
    Department of Obstetrics and Gynecology, Himeji National Hospital, 68 Honmachi, Himeji, Hyogo 670 8520, Japan
    Eur J Obstet Gynecol Reprod Biol 104:167-70. 2002
    ..Therefore, there were two kinds of neoplasia arising from different origins in the uterine corpus...
  10. ncbi Adenocarcinomas arising from uterine adenomyosis: a report of four cases
    Masafumi Koshiyama
    Department of Obstetrics and Gynecology, Osaka National Hospital, Chuoku, Japan
    Int J Gynecol Pathol 21:239-45. 2002
    ..Adenocarcinomas arising from adenomyosis are difficult to diagnose preoperatively, and their aggressive behavior in some cases seems to be related to the histological subtype...
  11. ncbi Rapidly growing leiomyoma in a postmenopausal woman
    Takako Okamoto
    Department of Obstetrics and Gynecology, Himeji National Hospital, Hyogo, Japan
    J Obstet Gynaecol Res 30:316-8. 2004
    ..The tumor weighed 4329 g, suggesting the rapid accumulation of 'hyaline fibrosis'. A small amount of proliferative activity was detected as evidenced by Ki-67 antigen immunoreactivity...
  12. ncbi Cystic ovarian lesions in SSFP diffusion imaging
    Yasushi Kaji
    Division of MR Imaging, Department of Radiology, Tenri Hospital, Kobe University School of Medicine, 7 5 2 Kusunoki cho, Chuo Ku, Kobe 650 0017, Japan
    Magn Reson Med Sci 1:183-9. 2002
    ..This study was performed to evaluate the usefulness of the steady-state free precession (SSFP) diffusion imaging of cystic ovarian lesions for analyzing cystic contents...
  13. ncbi Chemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatin
    Masafumi Koshiyama
    Department of Obstetrics and Gynecology, National Hospital Organization Himeji Medical Center, Himeji, Hyogo, 670 8520, Japan
    Anticancer Res 25:4499-502. 2005
    ..The tetrazolium dye (MTT) assay is useful for predicting chemosensitivity...